Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Scotia set CXR target price US$75 and rated outperformance
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(122)
•••
Comment by fdfd12on Feb 10, 2016 1:13pm
115 Views
Post# 24544267

RE:RE:RE:RE:RE:RE:Scotia set CXR target price US$75 and rated outperformance

RE:RE:RE:RE:RE:RE:Scotia set CXR target price US$75 and rated outperformance
I think that cashflow is more important than the EPS.
Anyone agree with me?

That 350M per year has to be reached to pay off the debt.
This stock is down because of its debt and people betting that they wont be able
to pay it off.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities